Cargando…

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer

CD164 was found to play a role in many malignant diseases. But the roles of CD164 in human bladder cancer have not yet been studied. The object of our study was to investigate the functions of CD164 in urothelial bladder carcinoma. The immunohistochemistry (IHC) was performed to evaluate the associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiao‐Guang, Zhang, Tong, Li, Chang‐Ying, Zhang, Ming‐Hao, Chen, Fang‐Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089154/ https://www.ncbi.nlm.nih.gov/pubmed/30022623 http://dx.doi.org/10.1002/cam4.1607

Ejemplares similares

Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Downregulation of miR‐133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
por: Chen, Xiaonan, et al.
Publicado: (2016)

Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
por: Liu, Zhaopei, et al.
Publicado: (2020)

PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer
por: Zhang, Min, et al.
Publicado: (2020)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164
por: Wei, Tao, et al.
Publicado: (2020)

High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma
por: Chen, Shuwei, et al.
Publicado: (2020)

Expression of CD81 and CD117 in plasma cell myeloma and the relationship to prognosis
por: Chen, Fang, et al.
Publicado: (2018)

Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma
por: Zhang, Qi, et al.
Publicado: (2021)

GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8(+) T cells infiltration in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
por: Zheng, Hui, et al.
Publicado: (2019)

CD164 regulates proliferation, progression, and invasion of human glioblastoma cells
por: Wang, Chung-Ching, et al.
Publicado: (2019)

High stromal nicotinamide N‐methyltransferase (NNMT) indicates poor prognosis in colorectal cancer
por: Song, Mengmeng, et al.
Publicado: (2020)

The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways
por: Tian, Xin‐Yuan, et al.
Publicado: (2020)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma
por: Abudureheman, Abulajiang, et al.
Publicado: (2018)

Upregulation of miR‐374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer
por: Zhang, Jun, et al.
Publicado: (2018)

HMGA2 promotes glioma invasion and poor prognosis via a long‐range chromatin interaction
por: Zhang, Shanshan, et al.
Publicado: (2018)

Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors
por: Shen, Yan‐Ying, et al.
Publicado: (2020)

Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer
por: Niu, Lijuan, et al.
Publicado: (2019)

Epstein–Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma
por: Xia, Bing, et al.
Publicado: (2019)

CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling
por: Zhang, Wen-Yuan, et al.
Publicado: (2019)

Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta‐analysis, and meta‐regression
por: Wen, Shu, et al.
Publicado: (2021)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population‐based study
por: Tian, Fang‐Xi, et al.
Publicado: (2018)

CCNI2 plays a promoting role in the progression of colorectal cancer
por: Lai, Dong‐Ming, et al.
Publicado: (2021)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)

Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma
por: Wei, Tao, et al.
Publicado: (2014)

Long non-coding RNA FTX predicts a poor prognosis of human cancers: a meta-analysis
por: Chen, Weiwei, et al.
Publicado: (2021)

Down-regulation of RBP4 indicates a poor prognosis and correlates with immune cell infiltration in hepatocellular carcinoma
por: Li, Mingxing, et al.
Publicado: (2021)

Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer
por: Yang, Song, et al.
Publicado: (2020)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

Poor prognostic and staging value of tumor deposit in locally advanced rectal cancer with neoadjuvant chemoradiotherapy
por: Wang, Yaqi, et al.
Publicado: (2019)

A novel upregulated LncRNA‐AC026150.8 promotes chemo‐resistance and predicts poor prognosis in acute myeloid leukemia
por: Zhang, Henan, et al.
Publicado: (2021)

The m(6)A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I–Mediated Immune Response
por: Zhang, Lei, et al.
Publicado: (2023)

The role of HOPX in normal tissues and tumor progression
por: Liu, Yijun, et al.
Publicado: (2020)

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma
por: Zhu, Sicong, et al.
Publicado: (2019)

Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
por: Hu, Mei-Di, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kcrf4ur1m3pqrhfpf8qb0q2o81